Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emend for CINV in AML Induction
NCT01334086Phase 2Completed
- Sponsor
- University Health Network
- Start
- Sep 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by University Health Network. Started Sep 2011; status: completed.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01334086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334086.